|
Volumn 29, Issue 1-2, 1997, Pages 51-55
|
Biological immunosuppressants: The way to clinical transplantation tolerance
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD23 ANTIGEN;
CD4 ANTIGEN;
CD8 ANTIGEN;
IMMUNOSUPPRESSIVE AGENT;
INTERCELLULAR ADHESION MOLECULE 1;
LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY CD3;
OKT 4;
OKT 8;
T LYMPHOCYTE ANTIBODY;
T LYMPHOCYTE RECEPTOR;
ALLOGRAFT;
CONFERENCE PAPER;
GRAFT SURVIVAL;
HUMAN;
IMMUNOGENICITY;
IMMUNOLOGICAL TOLERANCE;
IMMUNOREGULATION;
IMMUNOSUPPRESSIVE TREATMENT;
MITOGENICITY;
NONHUMAN;
PRIORITY JOURNAL;
T LYMPHOCYTE;
ANIMALS;
ANTIBODIES, MONOCLONAL;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSION;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
LYMPHOCYTE ACTIVATION;
MUROMONAB-CD3;
T-LYMPHOCYTES;
TRANSPLANTATION IMMUNOLOGY;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 0030944259
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(96)00719-1 Document Type: Conference Paper |
Times cited : (4)
|
References (44)
|